As an integral component of the ChAbS (Chinese Antibody Society) Annual Conference, the ChAbS has invited poster abstract submissions since 2023 to showcase emerging research, foster scientific exchange, and highlight innovative work in antibody science from both academia and industry . This poster abstract initiative has become a dedicated effort to provide a focused platform for technological advances that may not yet be ready for full-length presentations. In the 2025 annual meeting, we received strong engagement from the community, with more than 50 high-quality abstract submissions spanning antibody discovery, engineering, manufacturing, and clinical development, underscoring the growing impact and visibility of this poster program. Detailed information about the ChAbS and its mission can be found on the official website: https://www.chabs.org.

This year, we warmly welcome abstract submissions for the 2026 ChAbS Annual Conference and encourage researchers from academia and industry to share their latest findings, ideas, and innovations with the ChAbS community.

What to Submit

We welcome abstract submissions covering all aspects of therapeutic antibodies, including but not limited to:

• Novel antibody modalities and formats

• Innovative technologies in antibody discovery, engineering, and development

• Advances in antibody manufacturing, formulation, and process development

• Preclinical and clinical progress of antibody-based therapeutics, including key data updates

Content of Abstract

Each abstract should include the following components:

1. An introductory paragraph describing the background and rationale of the study;

2. A brief description of the relevant experimental procedures or methodologies;

3. A summary of the main results, including new and unpublished data; and

4. A statement of discussion and conclusions.

Authors are asked to refrain from using terminology that may be considered objectionable in accordance with current U.S. administration policy guidelines.

Length of Abstract

The abstract body must not exceed 2,600 characters, excluding spaces and the author list. Abstracts exceeding this limit may be truncated during the review process.

Abstract Submission Deadline

The deadline for abstract submission is 11:59 p.m. (U.S. Eastern Time) on Tuesday, March 31, 2026.

Submission Guidelines

• Please ensure that your abstract is submitted in its final version, as revisions will not be accepted after submission.

• Once you click the ‘submit‘ button, a confirmation message stating “Your abstract has been submitted. Please contact poster@chabs.org if you have any questions. Thank you!“ will appear, indicating that your submission has been successfully received.

• Approximately 20 abstracts will be selected for on-site poster presentations. Notification of acceptance will be sent in mid to late April. Among these, the top three abstracts will be invited to deliver a 10-minute oral presentation during the conference and to submit a full-length manuscript to the society’s official journal, Antibody Therapeutics for consideration of publication.

• For questions or additional information, please contact us at poster@chabs.org.